AGAM
BSX icon

Avalon Global Asset Management’s Boston Scientific BSX Stock Holding History

Avalon Global Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-50,000
Closed -$1.17M – 43
2016
Q2 		$1.17M Buy
+50,000
New +$1.08M 0.67% 39

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Avalon Global Asset Management's BSX Position: Q3 2016 in Review

Avalon Global Asset Management sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 50,000 shares — an estimated $1.17M sold.

Avalon Global Asset Management first reported a position in BSX in Q2 2016 and held it in 1 quarter. The position peaked at $1.17M in Q2 2016. 566 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Avalon Global Asset Management reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Avalon Global Asset Management sold 50,000 Boston Scientific shares in Q3 2016, an estimated $1.17M.
  • Avalon Global Asset Management first reported a position in Boston Scientific in Q2 2016 and held it in 1 quarter.
  • Avalon Global Asset Management's Boston Scientific position peaked at $1.17M in Q2 2016.
  • 566 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Avalon Global Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.